Molnupiravir
Molnupiravir is a potent nucleoside analogue and antiviral agent used in pharmaceutical research to study the inhibition of viral replication through RNA mutagenesis.
Description
Comprehensive Product Overview
In the field of infectious disease research, the ability to disrupt viral genetic consistency is a major advantage. Molnupiravir is specifically selected because it mimics naturally occurring nucleosides, allowing it to be incorporated into viral RNA. For instance, it is used to investigate the suppression of SARS-CoV-2 and Influenza virus replication. Consequently, it facilitates the development of high-efficacy oral antiviral therapies with higher efficiency. As a result, Zyntex ensures that our high-purity API is manufactured under rigorous analytical control to ensure consistent tautomeric stability and bioactivity.
[Image of the molecular structure of Molnupiravir]
Moreover, the research-grade Molnupiravir provided by Zyntex is a vital component in the study of viral “error catastrophe.” This application allows for the creation of advanced mutagenic profiles, undoubtedly pushing the boundaries of what is possible in modern molecular virology. At the same time, its broad-spectrum potential against various RNA viruses is highly valued by global clinical research organizations. In short, our product serves as a dependable “precision-antiviral” for companies focusing on both acute respiratory infections and sustainable healthcare infrastructure.
Recently, scientific interest has surged regarding the use of Molnupiravir in combination therapies to prevent viral resistance. Because of this, Zyntex offers specialized analytical documentation to provide safer and more convenient validation in high-containment laboratory environments. Ultimately, by choosing Zyntex as your supplier, you secure a reliable supply chain that balances chemical potency with rigorous logistical safety. To conclude, our commitment to chemical excellence ensures that your manufacturing processes—whether in fine chemistry or clinical research—achieve the highest levels of purity and yield.
Key Industrial Applications
This high-performance antiviral agent is specifically vital in the following four sectors:
🔬 Virology Research
A potent agent for studying RdRp inhibition; thus enabling the production of high-value viral replication data.
💊 Pharma Development
Key API for oral antiviral formulation; consequently vital for developing stable, broad-spectrum medications.
🧬 Genetic Sequencing
Used in mutagenesis assays; undoubtedly essential for identifying viral evolutionary bottlenecks.
🧪 Clinical Diagnostics
Used as a reference standard in antiviral susceptibility tests; specifically helping researchers monitor emerging variants.
Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Molnupiravir |
| Assay / Purity | Min. 99.0% |
| Molecular Formula | C13H19N3O7 |
| CAS Number | 2349386-89-4 |
⚠️ Safety Warning: Molnupiravir is a potent mutagenic antiviral agent. Therefore, it must be handled under strict laboratory protocols by trained personnel using appropriate PPE. Store at -20°C for long-term stability and protect from light and moisture to prevent hydrolysis of the ester bond.
Safety and Regulatory Data
For comprehensive toxicological profiles, material safety data sheets (MSDS), and physical property validation, please refer to the official PubChem entry: Chemical Safety Data – Molnupiravir (2349386-89-4)
